Getty ImagesShare price of Ltd. gained 0.23 per cent to Rs 1176.7 at 01:55PM (IST) in Thursday's trade. The counter hit a high of Rs 1181.15 and low of Rs 1170.75 so far during the session. The stock had closed at Rs 1174.05 in the previous session.
The counter had a total traded volume of 01:55PM shares so far with a turnover of Rs 11.57 crore on BSE. The stock traded at a price-to-earnings multiple of 43.84 and a price-to-book ratio of 2.13.
A higher P/E ratio shows investors are willing to pay a higher price for per rupee earnings given by the stock because of better future growth expectations.
The price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Lupin Ltd. belongs to the Pharma - Indian industry.
Promotor/FII Holding
Promoters held 46.84 per cent stake in the company as of 30-Jun-2021, while overseas investors and domestic institutional investors ownership stood at 18.6 per cent and 21.81 per cent, respectively.
Key Financials
The company reported consolidated sales of Rs 3841.32 crore for the quarter ended 31-Mar-2021, down 4.88 per cent from the previous quarter's Rs 4038.53 crore and down 5.25 per cent from the year-ago quarter's Rs 4054.34 crore.
Its profit for the latest quarter stood at Rs 460.36 crore, up 18.15 per cent from the same quarter a year ago.
The counter had a total traded volume of 01:55PM shares so far with a turnover of Rs 11.57 crore on BSE. The stock traded at a price-to-earnings multiple of 43.84 and a price-to-book ratio of 2.13.
A higher P/E ratio shows investors are willing to pay a higher price for per rupee earnings given by the stock because of better future growth expectations.
Did you Know?
Stock score of Lupin Ltd moved up by 1 in a week on a 10-point scale.
View Latest Stock Report »The price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Lupin Ltd. belongs to the Pharma - Indian industry.
Promotor/FII Holding
Promoters held 46.84 per cent stake in the company as of 30-Jun-2021, while overseas investors and domestic institutional investors ownership stood at 18.6 per cent and 21.81 per cent, respectively.
Key Financials
The company reported consolidated sales of Rs 3841.32 crore for the quarter ended 31-Mar-2021, down 4.88 per cent from the previous quarter's Rs 4038.53 crore and down 5.25 per cent from the year-ago quarter's Rs 4054.34 crore.
Its profit for the latest quarter stood at Rs 460.36 crore, up 18.15 per cent from the same quarter a year ago.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.